We released the DEX in November last year. So I do not know what you talking about
The team shouldn’t do marketing until they fix the trading experience. It is the most frustrating UI trading experience I’ve had on a derivatives platform. ✅ The process to enter an order is far too slow for an active trader. MMs adjust orders before an order can even be submitted. ✅ The FBA system provides horrible fills if a limit order is used to control max price of a market buy. ✅ Market orders will not allow high leverage. ✅ The margin threshold is far too high. ✅ There are no stoplosss orders. This derivative DEX is not ready for prime-time and therefore should not be marketed until these issues are fixed. It simply can’t be competitive as is.
does snx or dydx suffer from this issues as well?
Dydx is centralised for all practical purposes. SNX just see the volume, you will understand.
Dont know about SNX but DYDX doesnt and neither does GNS so thats at least two major competitors in the space.
Обсуждают сегодня